Pharmx seals multi-year Sigma alliance to become core EDI partner and secure strategic stake

PharmX Technologies ( (AU:PHX) ) has issued an update.

Pharmx Technologies has entered a binding multi-year strategic alliance with Sigma Healthcare, one of Australia’s largest pharmaceutical wholesalers and retail pharmacy operators, positioning Pharmx as a core technology infrastructure partner to Sigma and the Chemist Warehouse network. Under the deal, Pharmx becomes the preferred EDI provider for Sigma wholesale and Chemist Warehouse retail operations in Australia and New Zealand, while still operating independently across the wider ANZ pharmacy market.

The alliance will be rolled out in two phases, with Part A including a five-year renewal of Sigma’s wholesale EDI contracts, Pharmx supporting Sigma’s New Zealand expansion, and Sigma taking an initial 10% equity stake and a board seat. Part B will extend Pharmx’s services into additional international markets and solution areas, with Sigma able to increase its shareholding to 19.9% over time, as both parties target enhanced supply chain efficiency, expanded data analytics capabilities and potential long-term revenue growth, despite near-term financial impacts remaining unquantified.

More about PharmX Technologies

Pharmx Technologies Limited is an Australia-based provider of electronic data interchange and digital infrastructure solutions for the pharmacy and healthcare sector. The company operates platforms including Gateway, Marketplace and Analytics, serving major wholesalers, suppliers, vendors and pharmacies across Australia and New Zealand as an independent, whole-of-market technology partner.

Average Trading Volume: 652,515

Technical Sentiment Signal: Buy

Current Market Cap: A$83.93M

For an in-depth examination of PHX stock, go to TipRanks’ Overview page.